Back to P& PAULSON & CO. INC.
BHCShowing 8 of 27 quarters
Position history for P&PAULSON & CO. INC.'s holdings in Valeant Pharmaceuticals Intern
PAULSON & CO. INC. holds 73.3M shares of BHC (Valeant Pharmaceuticals Intern), worth $361.2M as of 2026-Q2. BHC represents 14.0% of PAULSON & CO. INC.'s portfolio.
Current Value
$361.2M
Current Shares
73.3M
Total Value Change
+$145.4M
Total Shares Change
+46.8M
Quarter-by-Quarter History
Other major holders of BHC: BNP PARIBAS FINANCIAL MARKETS, ICAHN CARL C